Contact
Please use this form to send email to PR contact of this press release:
New ‘Blood Advances®’ Publication Supports Humanigen’s GM-CSF Neutralization Strategy with Lenzilumab in GvHD
TO:
Please use this form to send email to PR contact of this press release:
New ‘Blood Advances®’ Publication Supports Humanigen’s GM-CSF Neutralization Strategy with Lenzilumab in GvHD
TO: